Company attributes
Venture Capital Firm attributes
Other attributes
Salveo Capital is a private equity firm in Chicago that focuses on the legalized cannabis industry. Founded 2015 in Chicago, Illinois by Michael Gruber, it invests in debt, early stage ventures, private equity, and seed. Its portfolio companies include PathogenDx, Front Range Biosciences, Coda Signature, KelSie Biotech, Ascend Wellness, Wurk, Harborside, and Treez. As of March 2020, Salveo Capital has made 17 investments. Their most recent investment was on September 30, 2019, when PathogenDx raised $7.5M. Salveo Capital has raised a single venture fund, Salveo Fund I. This fund was announced on September 11, 2019 and raised a total of $22.3M. The firm seeks to invest in the cultivation centers, dispensaries, ancillary products, industry support services, software, and technology sectors surrounding the legal marijuana industry.
